Literature DB >> 8783708

Cytomegalovirus pneumonia in adult nontransplantation patients with cancer: review of 20 cases occurring from 1964 through 1990.

J R Mera1, E Whimbey, L Elting, A Preti, M A Luna, J M Bruner, T Williams, G P Bodey, J M Goodrich.   

Abstract

The objectives of this study were to estimate the frequency of cytomegalovirus (CMV) pneumonia and describe its clinical and radiological presentation in adult nontransplantation patients with cancer. Of the 10,441 autopsies performed at M. D. Anderson Cancer Center (Houston) during the period of January 1964 through December 1990, 9,029 were evaluable. Twenty histopathologically confirmed cases of CMV pneumonia were found, representing a frequency of 2.2 cases per 1,000 autopsies. When the frequency of CMV pneumonia was compared for the periods 1964-1979 (1.5 cases per 1,000 autopsies) and 1980-1990 (4.6 cases per 1,000 autopsies), a statistically significant increase due to an increase in the number of patients with solid malignancies was observed (P < .05). CMV pneumonia is an uncommon diagnosis at autopsy for adult nontransplantation patients with cancer and is usually found in conjunction with a disseminated neoplastic process.

Entities:  

Mesh:

Year:  1996        PMID: 8783708     DOI: 10.1093/clinids/22.6.1046

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  9 in total

Review 1.  A persistent challenge: the diagnosis of respiratory disease in the non-AIDS immunocompromised host.

Authors:  C Mayaud; J Cadranel
Journal:  Thorax       Date:  2000-06       Impact factor: 9.139

Review 2.  The impact of inflationary cytomegalovirus-specific memory T cells on anti-tumour immune responses in patients with cancer.

Authors:  Xiao-Hua Luo; Qingda Meng; Martin Rao; Zhenjiang Liu; Georgia Paraschoudi; Ernest Dodoo; Markus Maeurer
Journal:  Immunology       Date:  2018-09-10       Impact factor: 7.397

Review 3.  The pulmonary physician in critical care. Illustrative case 2: interstitial lung disease.

Authors:  A T Jones; R M du Bois; A U Wells
Journal:  Thorax       Date:  2003-04       Impact factor: 9.139

4.  Pulmonary cytomegalovirus reactivation causes pathology in immunocompetent mice.

Authors:  Charles H Cook; Yingxue Zhang; Daniel D Sedmak; Larry C Martin; Scott Jewell; Ronald M Ferguson
Journal:  Crit Care Med       Date:  2006-03       Impact factor: 7.598

5.  Cytomegalovirus Colitis during Dasatinib Treatment for Patients with Hematologic Malignancy: Case Series and Literature Review.

Authors:  Jae Ki Choi; Sung Yeon Cho; Su Mi Choi; Gyo Hui Kim; Sung Eun Lee; Seok Lee; Dong Wook Kim; Dong Gun Lee
Journal:  Infect Chemother       Date:  2018-06

Review 6.  Cytomegalovirus pneumonia: community-acquired pneumonia in immunocompetent hosts.

Authors:  Burke A Cunha
Journal:  Infect Dis Clin North Am       Date:  2010-03       Impact factor: 5.982

7.  Effects of intrapulmonary viral tropism and cytokine expression on the histological patterns of cytomegalovirus pneumonia.

Authors:  Yoshifumi Arai; Takashi Tsuchida; Isao Kosugi; Hideya Kawasaki; Shiori Meguro; Mana Kinoshita; Satoshi Baba; Matsuyoshi Maeda; Yuichiro Shinmura; Yoshihiro Tsutsui; Toshihide Iwashita
Journal:  Pathol Int       Date:  2012-09       Impact factor: 2.534

8.  Cytomegalovirus reactivation and its clinical impact in patients with solid tumors.

Authors:  Konstantin Schlick; Michael Grundbichler; Jutta Auberger; Jan Marco Kern; Markus Hell; Florian Hohla; Georg Hopfinger; Richard Greil
Journal:  Infect Agent Cancer       Date:  2015-12-03       Impact factor: 2.965

9.  Severe cytomegalovirus (CMV) community-acquired pneumonia (CAP) in a nonimmunocompromised host.

Authors:  Burke A Cunha; Francisco Pherez; Nicole Walls
Journal:  Heart Lung       Date:  2008-10-01       Impact factor: 2.210

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.